2013
DOI: 10.1021/ic4004824
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism Elucidation of thecis–transIsomerization of an Azole Ruthenium–Nitrosyl Complex and Its Osmium Counterpart

Abstract: Synthesis and X-ray diffraction structures of cis and trans isomers of ruthenium and osmium metal complexes of general formulas (nBu4N)[cis-MCl4(NO)(Hind)], where M = Ru (1) and Os (3), and (nBu4N)[trans-MCl4(NO)(Hind)], where M = Ru (2) and Os (4) and Hind = 1H-indazole are reported. Interconversion between cis and trans isomers at high temperatures (80–130 °C) has been observed and studied by NMR spectroscopy. Kinetic data indicate that isomerizations correspond to reversible first order reactions. The rates… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
3
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 86 publications
(114 reference statements)
2
24
3
1
Order By: Relevance
“…Ruthenium and osmium analogues showed a striking difference in antiproliferative activity in three human cancer cell lines, A549 (nonsmall cell lung carcinoma), CH1 (ovarian carcinoma), and SW480 (colon carcinoma). 14,15 These results were in strong contrast to previous comparative studies on homologous ruthenium and osmium complexes (with metal ion in different oxidation states) showing either similar activities 16,17 or much smaller differences 1820 than those observed for compounds reported in reference (15). We are now trying to find out whether their behavior toward amino acids can provide an explanation for their different antiproliferative activity.…”
Section: Introductioncontrasting
confidence: 99%
“…Ruthenium and osmium analogues showed a striking difference in antiproliferative activity in three human cancer cell lines, A549 (nonsmall cell lung carcinoma), CH1 (ovarian carcinoma), and SW480 (colon carcinoma). 14,15 These results were in strong contrast to previous comparative studies on homologous ruthenium and osmium complexes (with metal ion in different oxidation states) showing either similar activities 16,17 or much smaller differences 1820 than those observed for compounds reported in reference (15). We are now trying to find out whether their behavior toward amino acids can provide an explanation for their different antiproliferative activity.…”
Section: Introductioncontrasting
confidence: 99%
“…27,28 ( n -Bu 4 N)[ cis -OsCl 4 (NO)(Hind)] ( 5c ) and ( n -Bu 4 N)[ trans -OsCl 4 (NO)(Hind)] ( 5t ) were prepared by reaction of ( n -Bu 4 N) 2 [OsCl 5 (NO)] with 1 H -indazole and separated by fractional crystallization. 29 l (+)-Ascorbic acid was obtained from Acros, and ubiquitin (bovine erythrocytes) and myoglobin (equine heart) from Sigma. The solvents for ESI-MS studies were methanol (VWR Int., HiPerSolv CHROMANORM), formic acid (Fluka), and Milli-Q water (18.2 MΩ, Synergy 185 UV Ultrapure Water System, Millipore, France).…”
Section: Experimental Sectionmentioning
confidence: 99%
“…To a solution of ( n -Bu 4 N)[ trans -OsCl 4 (NO)(Hind)] 29 ( 5t ) (200 mg, 0.27 mmol) in water/ethanol 1:1 (250 mL) was added ion exchanger Dowex Marathon C Na + -form (25 g). The suspension was stirred for 12 h, the ion exchanger was separated by filtration, and the solution lyophilized to give a blue solid.…”
Section: Experimental Sectionmentioning
confidence: 99%
“…59 The reduction of osmium(IV) to osmium(III) with NaBH 4 was performed as described previously for [ 3 ] − 29 and [ 1 ] − was isolated as its tetra- n -butylammonium salt ( n Bu 4 N[ 1 ]). Cation metathesis employing an ion exchange resin 60 afforded the sodium salt Na[ 1 ].…”
Section: Resultsmentioning
confidence: 99%